This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
14 Feb 2017 | North America | Market Research
Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market
Growing Prominence of Single Use Technologies and Biologics Market Driving Growth
This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is ...
$1,500.00 -
18 Jan 2017 | North America | Market Research
Disruptive Technologies and Game-changing Companies in the Global Pharmaceutical Cell Banking Market
Proprietary CMO Cell Culture Technology Platforms are Disrupting the In-house-outsourced Balance of Cell Banking Services
This market insight on the global cell banking market analyses disruptive technologies and provides details on game-changing companies. Biopharmaceutical companies are increasingly partnering with CMOs and CROs to store their proprietary cell lines and develop new ones. With increased collaborations, CMOs are coming up with niche and specific servi...
$1,500.00 -
13 Jan 2017 | North America | Market Research
Global Pharmaceutical Stability Testing Market Trends, Opportunities, and Future
Consolidated Stability Storage is Leading to CROs Evolving into Development Partners and Driving the Stability Testing Outsourcing Market
This research service on the global pharmaceutical stability testing market addresses market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year is 2015 and forecasts are provided from 2016 to 2020. The market is expected to grow at a CAGR of 9.4% till 2020, driven by an explosio...
$1,500.00 -
11 Jan 2017 | North America | Market Research
Global Cell Banking Market Trends, Opportunities, and Future
As Outsourcing of Cell Line Development Services Drives the Market, Contract Service Providers Focus on Providing End-to-end Services by Expanding the
This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020. The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by special...
$1,500.00 -
09 Jan 2017 | North America | Customer Research
2016 Global Survey on Clinical Next-Generation Sequencing
Respondents Show Vivid Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications
The primary goal of this research is to analyze the current and future adoption plans of Next-Generation Sequencing (NGS) for clinical applications. The survey seeks to collect the following key information: • Outsourcing needs and clinical NGS service providers • Current and future interest areas of clinical NGS • Genetic elements of in...
$4,950.00 -
02 Jan 2017 | North America | Market Research
Western European Molecular Diagnostics Market, 2015 Forecast to 2020
Prevalence and Prevention Driving Healthcare in Europe Toward Molecular Diagnostics Expansion and Innovation
Across the In vitro diagnostics Segment , including research and further upcoming disruptive technologies Across the Life Sciences landscape, including research tools, clinical diagnostics and pharma, disruptive technologies transform the complete the Healthcare decision making , and diagnostics trend . However, to take advantage of these opportun...
$4,950.00
